Get the Stockscreener App
1.54
1.19%
-0.02
Phio Pharmaceuticals Corp stock is traded at $1.54, with a volume of 128.72K.
It is down -1.19% in the last 24 hours and down -30.00% over the past month.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
See More
Previous Close:
$1.56
Open:
$1.53
24h Volume:
128.72K
Relative Volume:
0.05
Market Cap:
$8.85M
Revenue:
-
Net Income/Loss:
$-11.66M
P/E Ratio:
-0.1888
EPS:
-8.156
Net Cash Flow:
$-11.09M
1W Performance:
-17.13%
1M Performance:
-30.00%
6M Performance:
-12.42%
1Y Performance:
-47.75%
1-Day Range:
$1.5274
$1.56
1-Week Range:
$1.35
$1.80
52-Week Range:
$0.9657
$9.79
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
Name
Phio Pharmaceuticals Corp
Sector
Industry
Phone
(508) 767-3861
Address
411 SWEDELAND ROAD, KING OF PRUSSIA, MA
Compare PHIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHIO
Phio Pharmaceuticals Corp
|
1.545 | 8.48M | 0 | -11.66M | -11.09M | -8.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
413.07 | 103.89B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
660.30 | 69.11B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.39 | 58.49B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
861.54 | 52.62B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.78 | 40.46B | 447.02M | -1.18B | -906.14M | -6.1812 |
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-05-25 | Resumed | H.C. Wainwright | Buy |
| Aug-05-20 | Initiated | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp Stock (PHIO) Latest News
How Phio Pharmaceuticals Corp. (44R1) stock reacts to fiscal policies2025 Earnings Impact & Momentum Based Trading Ideas - newser.com
Best data tools to analyze Phio Pharmaceuticals Corp. stockWeekly Market Report & Comprehensive Market Scan Reports - newser.com
Top chart patterns to watch in Phio Pharmaceuticals Corp.Quarterly Profit Report & Community Verified Watchlist Alerts - newser.com
Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762 - Newsfile
Phio Pharma (NASDAQ: PHIO) to present Phase 1b PH-762 skin cancer results at SITC - Stock Titan
Phio’s INTASYL PH-762 wins immunomodulatory solution of the year By Investing.com - Investing.com South Africa
Phio’s INTASYL PH-762 wins immunomodulatory solution of the year - Investing.com
Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program - Newsfile
Phio Pharma (NASDAQ: PHIO) named Immunomodulatory Solution of the Year for PH-762 - Stock Titan
How Phio Pharmaceuticals Corp. (44R1) stock reacts to new regulationsStop Loss & Stepwise Trade Signal Implementation - newser.com
Phio Pharmaceuticals Exercises Warrants for $13.4 Million - TipRanks
Is Phio Pharmaceuticals Corp. stock in correction or buying zoneJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
Can Phio Pharmaceuticals Corp. hit a new high this monthAnalyst Downgrade & Daily Price Action Insights - newser.com
How Phio Pharmaceuticals Corp. stock benefits from tech adoptionGlobal Markets & Expert Curated Trade Setup Alerts - newser.com
Is Phio Pharmaceuticals Corp. stock attractive for retirement portfolios2025 Valuation Update & High Yield Stock Recommendations - newser.com
Using economic indicators to assess Phio Pharmaceuticals Corp. potentialWeekly Stock Summary & Expert Verified Movement Alerts - newser.com
How currency fluctuations impact Phio Pharmaceuticals Corp. stockWeekly Stock Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Developing predictive dashboards with Phio Pharmaceuticals Corp. dataEarnings Overview Summary & Weekly Top Gainers Trade List - newser.com
What to do if you’re stuck in Phio Pharmaceuticals Corp.2025 Trade Ideas & Stepwise Trade Signal Implementation - newser.com
Is Phio Pharmaceuticals Corp. (44R1) stock bottoming after sell offMarket Risk Analysis & Verified Stock Trade Ideas - fcp.pa.gov.br
Is Phio Pharmaceuticals Corp. (44R1) stock attractive for growth fundsTrade Analysis Summary & Safe Capital Growth Tips - newser.com
Is Phio Pharmaceuticals Corp. (44R1) stock included in top ETFsTrade Volume Summary & Free Growth Oriented Trading Recommendations - newser.com
3 Penny Stocks to Watch Now, 11/4/25 - TipRanks
Will Phio Pharmaceuticals Corp. stock outperform tech sector in 2025July 2025 Momentum & Weekly Market Pulse Alerts - newser.com
Can Phio Pharmaceuticals Corp. rally from current levelsMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Phio Pharmaceuticals raises $13.4 million through warrant exercise By Investing.com - Investing.com Nigeria
Can PHIO Bounce Back? - timothysykes.com
Phio Pharmaceuticals Stock Falls 5% Amid Financing And Clinical Updates - Nasdaq
Phio Pharmaceuticals raises $13.4 million through warrant exercise - Investing.com India
Phio (NASDAQ: PHIO) to get $13.4M as 5.66M warrants exercised in two tranches - Stock Titan
Why Is Phio Pharmaceuticals Stock Soaring Today? - Benzinga
Why Is Phio Pharmaceuticals Stock Up 75% Today? - TipRanks
Phio’s skin cancer treatment shows promising tumor clearance results By Investing.com - Investing.com Canada
Phio Pharmaceuticals Reports Positive Phase 1b Trial Results - TipRanks
Phio Pharmaceuticals Corp Announces Positive Results in Skin Cancer Trial - TradingView
Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial - Markets Financial Content
Phio Pharmaceuticals Corp. stock retracement – recovery analysisMarket Risk Report & Real-Time Volume Trigger Notifications - newser.com
Phio Pharmaceuticals Corp Stock (PHIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Phio Pharmaceuticals Corp Stock (PHIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ferrara Robert L | Director |
Jun 10 '25 |
Buy |
2.42 |
2,500 |
6,050 |
15,666 |
| Bitterman Robert J | Chairman, Pres & CEO |
Jun 09 '25 |
Buy |
2.75 |
1,500 |
4,125 |
25,149 |
| Bitterman Robert J | Chairman, Pres & CEO |
May 21 '25 |
Buy |
1.77 |
3,000 |
5,310 |
22,449 |
| Bitterman Robert J | Chairman, Pres & CEO |
May 22 '25 |
Buy |
1.78 |
1,200 |
2,136 |
23,649 |
| Ferrara Robert L | Director |
May 20 '25 |
Buy |
1.82 |
2,500 |
4,550 |
13,166 |
0.91%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):